- Gene Therapy Zolgensma Gains Approval In Spinal Muscular Atrophy Treatment; Novartis Stock PopsInvestor’s Business Daily
- At $2.1M, Novartis gene therapy will be world’s most expensive drugSTAT
- At $2M, priciest ever medicine treats fatal genetic diseaseSF Gate
- U.S. regulators approve most expensive medicine ever: $2.1 million to treat fatal disease in babiesCBS News
- No Miracle Drug Should Cost $2.1 MillionBloomberg
- View full coverage on Google News